AIM ImmunoTech to present Ampligen oncology data at Roswell Park symposium

AIM ImmunoTech Inc.

Chris McAleer, Ph.D., Scientific Officer, will present at the Marie Sklodowska-Curie Symposium on Cancer Research and Care at Roswell Park.
Company also sponsors the symposium; presentation titled 'Rintatolimod (Ampligen): Overview of Ampligen’s Clinical Progress in Oncology'.
No new clinical results or financial data disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.